Market Overview

Premarket Approval Doc For Balloon System Sends Obalon Shares Sharply Higher


Obalon Therapeutics (NASDAQ: OBLN) shares spiked about 30 percent following circulation of a Food and Drug Administration document for the weight loss Obalon balloon system.

The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity.

Obalon Therapeutics traded at $1.47 per share at time of publication, up 12 percent.

Related Link:

Obalon Closes Above $1 Following Questionable Takeover Rumor


Related Articles (OBLN)

View Comments and Join the Discussion!

Posted-In: News FDA Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at